Downs syndrome and cardiac surgery, a dilemma, should we operate or not? Ghada Shiekh Abdullah, Shehla Jadoon, Milad Elsegaier, M.O. Galal Background: Incidence of congenital heart disease in patients with Down syndrome (DS) is 40%. In the past some have advocated that the cardiac defects in DS should not be repaired, reports had shown outcome comparable to individuals without DS. The aim of the study is to analyze the outcome of cardiac surgery in DS.
Methods: In Abu Dhabi, information on medications dispensed during one year following a hospitalized AMI during January 2010 to June 2011 (n = 1,326) was retrieved from the Health Authority of Abu Dhabi's administrative claims database. Rates of at least one prescription within selected classes were quantified immediately following the event (months 0-3), 4-6 months, and 10-12 months after the event. Similar data was collected for hospitalized AMI patients in Sweden during 2009 (n = 19,312) , by linkage of the Swedish Myocardial Infarction register and Prescribed Drug Register. All proportions were agestandardized.
Results: During the first three months post-AMI, the proportion of patients in Abu Dhabi with at least one prescription of an anti-hypertensive drug was 76%, statin 72%, platelet aggregator inhibitor 76%, beta-blocker 64%, and drugs affecting the renin-angiotensin system only 56%. These proportions declined to 36%, 34%, 34%, 28% and 28%, respectively, during month 10-12. Reductions among UAE citizens were somewhat lower than among expatriates. In Sweden, the corresponding proportions were 90%, 82%, 89%, 83% and 68%, respectively, 10-12 months post-AMI.
Conclusion: Abu Dhabi's health data systems offer a valuable tool for monitoring adherence to drug use. It appears that the outcomes of AMI patients in Abu Dhabi could be substantially improved by promoting adherence to evidence-based guidelines for secondary prevention. is an autoimmune disease that primarily affects young women. According to the literature, the prevalence of cardiovascular involvement in patients with systemic lupus erythematosus (SLE) has been estimated to be more than 50%.
Valvular involvement is the most frequent cardiac manifestation in SLE. Functionally, valvular regurgitation hasbeen reported to occur in up to 74% of patients. Meanwhile valvular endocarditis is a frequent manifestation of SLE, and the mitral valve is most frequently affected. However, any valve or multivalvular affection may occur.
Valvular lesions resulting from lupus can cause severe mitral regurgitation (MR). The most classic cardiac valvular abnormality in patientswith SLE is known as Libman-Sacks endocarditis, which consists of noninfective, verrucousvegetations(marantic endocarditis). They occur most frequently onthe mitral valve. Most of the valves that have vegetations are usually associated with diffuse thickeningor regurgitation.
However, although cardiac involvement in patients with SLE has been recognized since the early 20th, But cardiac surgery was infrequently performed in patients with SLE, and its clinical outcome was reported only in small series. Also the impact of SLE on provision of anesthesia has never beeninvestigated, and the lack of evidence combined with theheterogeneity of disease manifestations makes it difficult toestablish definitive management protocols.
That's why, We herein describe a 22 years old female patient with SLE,with end stage renal diseaserequiring peritoneal dialysis. presented to our hospital (Al-Demerdash, Ain Shams University Hospital), with signsof congestiveheart failure such as dyspnea on exertion andorthopnea, paroxysmal nocturnal dyspnea, and fatigue, refractory to medical management.Her therapy for SLE required longterm prednisolonand hydroxychloroquine.
Physical examination revealed no facial malar rash or generalized discoid rashes. The breath sounds were diminished at the lower lung zones. Cardiac auscultation showed regular heart beat with a heart rate of 102 beats/ min, a grade III/VI systolic murmur at the left lower sternal border and the apex, and a pericardial friction rub. Palpation of the abdomen showed hepatomegaly. The extremities were notable for mild pitting edema. There was no clubbing, cyanosis or deformity of joints.
Preoperative data: Complete blood count revealed Hg 9.9 g/dl, WBC 11.100/ul, Platelet 247,000/ul. Bleeding Profile showed PT 16.4 sec, INR 1.45, PTT 44 sec. biochemistry work-up showed, Glucose 75 mg/dl, Creat 2.9 mg/dl with hemodialysis session, ALT 15U/l, AST 20U/l. Preoperative transesophageal Echocardiography showed: A large mass is attached to the atrial surface of the anterior mitral leaflet measuring 6 Â 7 mm. the mass perforates the leaflet causing severe mitral regurgitation. And, another large mass measuring 6 Â 9 mm attached to the non-coronary aortic valve cusp with 2 small masses attached to each of the other two leaflets causing severe aortic regurgitation.EF 60%,RVSP 50 mmHg.
So the patient was scheduled for double valve replacement. Although valve repair and bioprosthetic valve replacement are not the best solution, since accelerated native valve and bioprosthetic valve calcification tend to occur because of the high calcium turnover. Also Porcine valves have become affected by valvulitiswith perforation of valve cusps.
But, our cardiac surgical team decided to replace mitral and aortic valve with bioprothetic valve, as they believe that Anticoagulation may present higher risks in our young patient who require prolonged steroid use and who have end stage renal failure, the resultant dependence on dialysis. Also previous reports described patients with SLE who underwent mitral valve replacement, had a number of complications, and died secondary to anticoagulation. Also, because ofsuccessful placement of the porcine Carpentier-Edwards bioprosthesis in patients with SLE has been reported before.
Finally weaning from cardiopulmonary bypass was uneventful (adrenaline 50 n/kg/min). The patient's recovery from surgery was uncomplicated, and she was discharged on the 6th postoperative day.
In conclusion, although the postoperative complication is common, cardiac operation could be performed in patients with SLE. Results: The mean patients age was 78 ± 5,2 years and 52% were male. The mean logistic EuroSCORE were 20,3 ± 10,8. Coronary artery disease were documented in 30 (60%) patients, including eight re-do procedures. In 15 (30%) cases were severe peripheral vasculopathy the main indication for DA access. Procedural success was 100%. Mean aortic gradient dropped immediately under 5 mm Hg, end diastolic left ventricle pressure improved on average by 30% in all patients and there was no vascular complications. Stroke occurred in one patient. 5 patients had, during the first days after the procedure, a psycho-organic syndrome, where a stroke was excluded. The post-operative echocardiogram demonstrated in 45 (90%) patients non to trace, in 4 (8%) patients mild and in 1(2%) patient moderate aortic regurgitation.
